Keywords: anti-infective, news, brief, boehringer, ingelheim, beginning, european

Anti-Infective News In Brief

Article | 19 March 1998

Boehringer Ingelheim is beginning the European roll-out of itsnon-nucleoside reverse transcriptase inhibitor Viramune (nevirapine) this month, it says, becoming the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Boehringer Ingelheim

Go to company listing

Related Drugs

Nevirapine

Viramune

Go to drug listing